1. EMA request name changes for high-risk liposomal medicines

   News item 12 October 2019 Pages: 1 - 1

2. EMA says companies should test for nitrosamine impurities

   News item 12 October 2019 Pages: 2 - 2

3. Febuxostat increases risk of death in patients with major CVD

   News item 12 October 2019 Pages: 3 - 3

4. HPRA advises recall of adrenaline auto-injector pens

   News item 12 October 2019 Pages: 4 - 4

5. Mandatory ADR reporting to soon begin in Canadian hospitals

   News item 12 October 2019 Pages: 5 - 5

6. US FDA recommends LC-HRMS for testing ranitidine products

   News item 12 October 2019 Pages: 6 - 6

7. Adverse event reporting patterns: Japan vs rest of world

   Clinical study 12 October 2019 Pages: 7 - 7

8. Antibacterial use before dental visits: risk of serious AEs

   Clinical study 12 October 2019 Pages: 8 - 8

9. Antibiotic adverse events in children with AOM

   Clinical study 12 October 2019 Pages: 9 - 9

10. Biologicals versus corticosteroids: less AEs, lower long-term costs

    Clinical study 12 October 2019 Pages: 10 - 10

11. Depressive symptoms in OCP users vary with age

    Clinical study 12 October 2019 Pages: 11 - 11

12. Inappropriate PPI use common after stopping NSAID or aspirin

    Clinical study 12 October 2019 Pages: 12 - 12

13. PADR-EC score reminds GPs of risks of ADRs

    Clinical study 12 October 2019 Pages: 13 - 13

14. Acenocoumarol

    Case report 12 October 2019 Pages: 14 - 14

15. Adalimumab

    Case report 12 October 2019 Pages: 15 - 15

16. Adalimumab

    Case report 12 October 2019 Pages: 16 - 16

17. Adalimumab/azathioprine

    Case report 12 October 2019 Pages: 17 - 17

18. Adalimumab/azathioprine

    Case report 12 October 2019 Pages: 18 - 18

19. Adalimumab/budesonide/infliximab/methotrexate

    Case report 12 October 2019 Pages: 19 - 19

20. Adalimumab/corticosteroids/mesalazine

    Case report 12 October 2019 Pages: 20 - 20

21. Afatinib/cetuximab

    Case report 12 October 2019 Pages: 21 - 21

22. Alemtuzumab

    Case report 12 October 2019 Pages: 22 - 22

23. Aminocaproic acid/desmopressin/ticagrelor

    Case report 12 October 2019 Pages: 23 - 23

24. Amiodarone

    Case report 12 October 2019 Pages: 24 - 24

25. Amiodarone/digoxin/flecainide

    Case report 12 October 2019 Pages: 25 - 25

26. Amiodarone/verapamil

    Case report 12 October 2019 Pages: 26 - 26

27. Angiogenesis-inhibitors/bisphosphonates

    Case report 12 October 2019 Pages: 27 - 27

28. Antibacterials

    Case report 12 October 2019 Pages: 28 - 28

29. Antibacterials

    Case report 12 October 2019 Pages: 29 - 29

30. Antibacterials

    Case report 12 October 2019 Pages: 30 - 30

31. Antibacterials/immunosuppressants

    Case report 12 October 2019 Pages: 31 - 31

32. Anticoagulants

    Case report 12 October 2019 Pages: 32 - 32

33. Antiepileptic drugs

    Case report 12 October 2019 Pages: 33 - 33

34. Antineoplastics

    Case report 12 October 2019 Pages: 34 - 34

35. Antineoplastics

    Case report 12 October 2019 Pages: 35 - 35

36. Antineoplastics

    Case report 12 October 2019 Pages: 36 - 36

37. Antineoplastics

    Case report 12 October 2019 Pages: 37 - 37

38. Antineoplastics

    Case report 12 October 2019 Pages: 38 - 38

39. Antineoplastics

    Case report 12 October 2019 Pages: 39 - 39

40. Antineoplastics

    Case report 12 October 2019 Pages: 40 - 40

41. Antineoplastics

    Case report 12 October 2019 Pages: 41 - 41

42. Antineoplastics

    Case report 12 October 2019 Pages: 42 - 42

43. Antineoplastics

    Case report 12 October 2019 Pages: 43 - 43

44. Antineoplastics

    Case report 12 October 2019 Pages: 44 - 44

45. Antineoplastics

    Case report 12 October 2019 Pages: 45 - 45

46. Antineoplastics/cotrimoxazole

    Case report 12 October 2019 Pages: 46 - 46

47. Antineoplastics/cytarabine

    Case report 12 October 2019 Pages: 47 - 47

48. Antineoplastics/folinic acid

    Case report 12 October 2019 Pages: 48 - 48

49. Antineoplastics/folinic acid

    Case report 12 October 2019 Pages: 49 - 49

50. Antineoplastics/folinic-acid

    Case report 12 October 2019 Pages: 50 - 50